Treatment with the autophagy inhibitor chloroquine results in a reversal of hypercoagulability in pancreatic cancer by diminishing NET mediated platelet aggregation and release of circulating tissue factor and improving coagulation index on TEG. The gene discussed is F3; the disease is pancreatic neoplasm.